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B A C K G R O U N D :  Health care workers (HCWs) are at 
greater risk for tuberculosis (TB), including multidrug-
resistant TB (MDR-TB), compared to the general popu-
lation. The psychosocial impact of nosocomial TB on 
HCWs has received little attention in the literature.
M E T H O D S :  A retrospective medical record review from 
1999 to 2003 found 15 HCWs who were treated for 
drug-resistant TB at a specialist hospital in South Africa. 
Five human immunodefi ciency virus (HIV) negative doc-
tors with no predisposing factors for drug resistance are 
included in this case series. We collectively present their 
clinical case histories based on medical records from 2000 
to 2005, and explore the long-term psychosocial impact 
of TB from interviews conducted in 2009.
R E S U LT S :  Four doctors had primary MDR-TB and 
one had primary resistance to multiple fi rst-line drugs. 
Time from symptom onset to commencement of effec-
tive treatment ranged from 8 to 39 weeks. Time for bac-
teriological confi rmation of drug-resistant TB ranged 
from 6 to 24 weeks. All were cured within 3 years of ini-
tial presentation. Content analysis of follow-up interviews 
revealed fi ve main themes: 1) prolonged morbidity, 2) psy-
chological impact, 3) poor infection control, 4) weak 
support structures and 5) attrition from the fi eld.
C O N C L U S I O N :  Themes emergent from this case series en-
courage prioritisation of TB infection control education 
and practice to minimise HCW morbidity and prevent 
HCW attrition from high-burden resource-constrained 
settings.
K E Y  W O R D S :  drug-resistant tuberculosis; health care 
workers; South Africa; infection control; psychosocial 
impact 
TUBERCULOSIS (TB) rates have resurged, largely 
from escalating human immunodefi ciency virus (HIV) 
infection and TB drug resistance. This is paralleled by 
increasing rates of TB, including multidrug-resistant 
TB (MDR-TB), among health care workers (HCWs).1–5 
While HIV signifi cantly contributes to the develop-
ment of TB in HCWs, nosocomial transmission re-
mains the strongest risk factor for initial exposure to 
TB infection.1,3,4,6–10 Between 1960 and 2005, the me-
dian prevalence of latent TB infection (LTBI) among 
HCWs in lower- and middle-income countries was 
reviewed to be 63%, while the median annual risk for 
active disease that could be attributed to health work 
was estimated as 5.8%.3 In high-burden countries, 
studies show that hospital exposures are associated 
with TB in HCWs even after controlling for other risk 
factors, suggesting that transmission occurs primarily 
from patients.6,8
In South Africa, TB incidence rates between 1999 
and 2004 increased from 1024 to 1640 per 100 000 
HCWs, nearly double the rate in the general popula-
tion. Three per cent of affected HCWs had MDR-
TB.5 In the national drug resistance survey, the over-
all proportion of MDR-TB was 1.8%–2.6% in new 
cases (primary MDR-TB) and 6.7% in retreatment 
cases.11 The psychosocial impact of developing TB as 
a result of occupational exposure, particularly among 
immunocompetent HCWs, has been poorly docu-
mented despite their integral role in the health care 
system. Human resource constraints warrant further 
examination of this issue. We present the cases of fi ve 
HIV-negative doctors in South Africa who were diag-
nosed with primary drug-resistant TB in 2000–2003 
and followed up in 2009, to explore the psychosocial 
impact of their illness.
METHODS
In a retrospective medical record review from 1999 
to 2003, 15 HCWs were managed for drug-resistant 
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TB at a specialist hospital. Five doctors who were 
HIV-negative with no previous history of TB are in-
cluded in this case series (Figure). We initially describe 
their clinical case histories based on medical records 
from 2000 to 2005 (‘disease’) and thereafter explore 
the long-term psychosocial impact of illness based on 
interviews conducted in 2009 (‘impact’). Findings are 
presented aggregately to protect participant identities.
Interviews were qualitative, semi-structured, 30–
45 min long and conducted privately by a single in-
terviewer. Interview domains focused on doctors’ 
quality of life post-treatment, work environment and 
present-day expressions of their TB experience, state 
of health and well-being. Transcribed interviews were 
content-analysed with open and analytic coding by 
two independent researchers towards the collective 
development of major themes.12,13 
All participants provided informed consent. The 
study was approved by the local ethics committee. 
(Details omitted to protect identities.)
RESULTS
Disease
One male and four female doctors were diagnosed 
with primary drug-resistant TB between 1999 and 
2003 while meeting their professional licensing re-
quirements in public health care facilities in South 
Africa. They included one medical student, one intern, 
two residents and one doctor completing a manda-
tory community service rotation. All were <30 years 
of age at the time of diagnosis. Four doctors met 
the classical case defi nition for MDR-TB, i.e., resis-
tance to both isoniazid (INH) and rifampicin (RMP).11 
Their clinical case histories are summarised in the 
Table.
The doctors presented with a range of symptoms, 
including fever, malaise, night sweats, rigours, pro-
ductive cough and lobar consolidation. Three doc-
tors initiated on antibiotic treatment remained un-
responsive 2–4 weeks later. Between 3 and 12 weeks 
after their initial case presentation, all doctors com-
menced empirical TB treatment while awaiting spu-
tum, sphenoidal sinus or cerebrospinal fl uid culture 
results. Bacteriological confi rmation of drug- resistant 
TB took 6 to 24 weeks, by which time symptoms 
had severely worsened. One doctor developed head-
ache, vomiting, neck stiffness and generalised seizure, 
followed by bilateral abducens nerve palsies and hydro-
cephalus, which mandated insertion of a ventriculo-
peritoneal shunt. Another doctor, who developed dis-
turbed balance, diplopia, diffi culty concentrating and 
was unable to stand, was eventually diagnosed with 
TB meningitis. Commencement of effective treatment 
for drug-resistant TB for the doctors ranged between 
8 and 39 weeks after initial presentation. Following 
up with appropriate treatment was particularly prob-
lematic for one doctor who had relocated across prov-
inces for recovery from what had been presumed to 
be a case of regular TB. 
The doctors experienced numerous adverse drug 
effects during their course of treatment, including 
nausea, depression, anxiety, labile emotions, insom-
nia, pruritic rash, limb weakness, bowel and bladder 
incontinence, and some mandating invasive or chronic 
medical intervention. Two doctors underwent a 
Figure Retrospective medical record review of HCW TB cases at a specialist hospital, South 
 Africa, 1999–2003. *Minimal clinical contact with living infectious cases. HCW = health care 
worker; TB = tuberculosis; HIV = human immunodefi ciency virus; MD = medical doctor.
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l obectomy. One doctor’s persistent limb weakness 
and resolving sixth nerve palsies required long-term 
physical rehabilitation, and another received exten-
sive psychological counselling for medication- related 
depression and anxiety. Another doctor’s raised in-
tracranial pressure necessitated rehabilitation and 
frequent cerebrospinal fl uid taps. All doctors were 
cured after receiving 18 and 36 months of TB 
treatment.
Impact
Several years after treatment completion, four of the 
fi ve doctors continue to experience adverse effects, 
ranging from hearing impairment to bilateral deaf-
ness from otosclerosis, tinnitus, anxiety with occa-
sional panic attacks, short-term memory impairment, 
weakness and pain in the shoulder and limbs, back 
spasms, sensory neuropathy and persistent loss of 
bladder and bowel control. For some, the severity of 
hearing loss and limb weakness or pain has not abated 
over time. 
Doctors with hearing loss tried to make use of 
hearing aids, but with limited success. Doctors ex-
periencing impaired bladder or bowel control rigor-
ously monitor their fl uid intake and wear adult dia-
per pads to the point of routinely catheterising and 
taking chronic preventive treatment against urinary 
infections. They avoid being outside their homes or 
offi ces for prolonged periods of time and feel uncom-
fortable discussing what they perceive to be an em-
barrassing situation outside of their immediate family 
members. One doctor requires the use of a wheel-
chair and has been in continuous rehabilitation pro-
grammes since initiating treatment. Only one of the 
fi ve doctors experiences no lasting complications, and 
was grateful to be ‘one of the lucky ones’, without 
permanent sequelae from drug-resistant TB. 
Doctors described the personal and professional 
stresses of carrying on work after being diagnosed 
with drug-resistant TB. They all returned to complete 
medical licensing requirements such as residencies, 
internships or community service rotations between 
8 and 24 months after initiating treatment. Several 
doctors experienced diffi culty and awkwardness re-
integrating into a teaching environment where their 
illness had been publicised, especially after having to 
battle with stubborn policies within academic divi-
sions to resume postings mid-semester. Intensive treat-
ment for MDR-TB may have impaired the doctors’ 
professional judgment, as one doctor expressed hav-
ing doubts around several clinical decisions made in 
the fi rst few weeks of resuming work. 
Most doctors described being poorly informed 
about their risks for TB when commencing medical 
practicums. ‘No one warns you about the risk you 
may be exposing yourself to’, said one doctor who 
received little support from the medical school dur-
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reported feeling ‘angry’ that they were poorly edu-
cated about nosocomial risks and the adverse effects 
of the surgical and medical treatments they endured 
for drug-r esistant TB. 
Doctors were all distressed about re-infection or 
relapse upon resuming work in public clinics and car-
ing for patients commonly presenting with TB and 
HIV. They described feeling ‘paranoid’ when consult-
ing a coughing or overtly ill patient, but all assumed 
that alternative training options were not viable at the 
time. They were sometimes offered face masks, but in 
most cases these were not easily accessible, secured by 
management and inaccessible after hours. One doctor 
obtained a supply of face masks through a respira-
tory specialist acquaintance. A few quickly realised 
that they were the only HCWs to employ personal 
protection measures and consequently felt margin-
alised from their co-workers and patients. Some ex-
pressed fi ghting between the urge to prioritise per-
sonal protection with the discomfort of specifi cally 
seeking out and wearing a cumbersome face mask. 
One doctor was upset by the contrasting mix of opin-
ions around infection control that was espoused by 
other HCWs, who rarely wore face masks themselves: 
‘Once, [a co-worker] at work said to me, “but you 
didn’t wear a mask?” . . . The hospital doesn’t under-
stand that the environment itself is such that you can-
not protect yourself’. To date, each doctor describes 
aggressively treating the mildest of fl u-like symptoms: 
‘[TB] is always in the back of my mind’, said one 
doctor.
One of the doctors, who has severe prolonged 
physical disability from MDR-TB and its treatment, 
has not worked since being diagnosed. This doctor 
would like to specialise further but is advised against 
any patient contact. The doctor contemplates pursu-
ing a non-clinical specialty, but persistent pain and 
weakness in the limbs preclude a concerted effort. 
‘I’m trying to get on with my life, being stuck in this 
hole’, the doctor stated.
Another doctor had already committed to special-
ising at the time of diagnosis, and completed resi-
dency while on treatment. All doctors believed that 
their own experience with drug-resistant TB clinched 
their decisions to leave general medicine as soon as 
possible. One doctor perceived that specialisation fa-
cilitated working in ‘a relatively cleaner fi eld, with 
no walk-ins’, and proceeded to specialise in a fi eld 
that promises minimal contact with infectious disease 
cases. One doctor found a niche within a practice 
that rarely serves patients presenting with undiag-
nosed infections. Although wanting to formally spe-
cialise and feeling ‘stagnated’ at not having done so, 
the doctor expressed a ‘lingering fear’ against at-
tending to ‘sick patients’. Finally, one doctor moved 
overseas soon after completing treatment to a work 
environment and specialty with almost no TB patient 
contact.
Emergent themes
Five major themes emergent from qualitative content 
analysis of the follow-up interviews and contextu-
alised by clinical case histories are discussed below.
Prolonged morbidity
All doctors responded favourably once appropriate 
treatment was commenced, but not without lingering 
adverse effects. Several doctors continue to experi-
ence diffi culty walking—a direct result of the infec-
tion. They also experience loss of bladder control, 
urinary infections and hearing impairment, which are 
irreversible treatment effects.14,15 Rehabilitation pro-
grammes and physical aids offer some recourse, but 
pain, compromised mobility and hearing dictate their 
places of practice and general ability to work. 
Psychological impact
The doctors experienced extensive psychological se-
quelae from TB, including depression, anxiety, resent-
ment and paranoia. Some lost contact with groups 
during extended absences from the workplace; others 
avoided congregate settings for fear of relapse. Pro-
longed physical debilitation compounded their sense 
of bitterness and helplessness. The physical and emo-
tional morbidity related to TB continues to impinge 
on their lifestyle several years after being cured.
Poor infection control
All doctors worked in poorly ventilated facilities, 
with overcrowded patient waiting areas and no spe-
cifi c strategy to mitigate airborne contagion. Although 
they had some awareness of nosocomial transmission, 
they felt insuffi ciently trained to implement infection 
control practices and counter exposure risks. Face 
masks were seldom available, and they had to be pro-
active and inventive to acquire personal supplies. Doc-
tors expressed feeling ashamed and blamed for acquir-
ing TB, as they were professionals who were expected 
to be fully aware of risk exposure yet ill-equipped to 
apply this knowledge to protect themselves.
Weak support structures
Doctors in training received varying support from 
their academic bases during recovery, despite having 
been assigned to high-risk settings by these same in-
stitutions over which the doctors had little choice. 
Some believed their medical backgrounds should have 
earned them greater support and compensation from 
the employer, in each case the State. They were disen-
chanted by the bureaucratic diffi culties faced with re-
suming work after having become patients themselves. 
Attrition from the fi eld
Several doctors returned to care for TB patients, but 
such work was short-lived, and they opted to leave 
general medicine upon fulfi lling their professional 
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obligations. All of these doctors currently practise in 
specialised fi elds, except for one who is unable to 
work. They each expressed concern about working 
with ‘sick’ or ‘coughing’ patients. They believe their 
personal experience with drug-resistant TB infl uenced 
their career trajectories in that they eventually se-
lected a specialty or work environment (or lack 
thereof) that they perceived would afford minimal 
exposure to infectious diseases.
DISCUSSION
This case series explores how primary drug-resistant 
TB may have impacted the lives of fi ve doctors in the 
early stages of their careers. The doctors had no pre-
disposing factors for drug resistance. In the absence 
of DNA fi ngerprinting confi rmation, nosocomial in-
fection appears to be the most likely mechanism of 
transmission. MDR-TB drug toxicities and long-term 
morbidity have been documented in non-HIV-infected 
patients despite successful treatment completion.16–18 
The psychosocial aftermath of TB, particularly HCWs’ 
emotional burden of illness, subsequent quality of life 
and return-to-work decisions, adds a critical perspec-
tive to the overall impact of the disease. Psychological 
support and professional counselling should be a rou-
tine part of conventional medical care for doctors 
with TB in high-risk settings.
Poor infection control within health care facilities 
may seriously compromise TB control strategies, par-
ticularly in high HIV prevalence settings. In this case 
series, bacteriological confi rmation of drug-resistant 
TB took 6–24 weeks, and commencement of effective 
treatment from case presentation ranged from 8 to 
39 weeks. During this time the doctors themselves 
may have contributed to an infectious pool of TB, fur-
ther aggravating nosocomial transmission. Negative-
pressure rooms, air fi ltering systems, isolation of TB 
suspects and confi rmed cases are routinely applied in 
high-income countries.19 However, they are generally 
unfeasible within resource-limited settings.7,20 Where 
funds for sustainable engineering solutions are inac-
cessible, the onus to reduce transmission falls upon 
HCWs themselves, via improved personal protection 
measures or effi cient TB case fi nding.7,21,22 Commen-
surate administrative efforts such as staff education, 
disbursement of protective masks/respirators, rapid 
laboratory diagnoses and sustained drug supplies 
should be applied in cohesion to signifi cantly reduce 
transmission.7,20–25 Adherence to legislation for occu-
pational safety is further mandated.
The risk for nosocomial TB is highest among young 
HCWs in high-burden countries, those in training or 
those most recently added to the workforce, as they 
tend to spend greater time with patients and are less 
aware of exposure risks compared to senior col-
leagues.8,10,26–28 Even when aware of nosocomial 
risks, implementation of personal protection measures 
among HCWs is generally low.1,29,30 Within middle- 
and low-income countries, TB transmission is also 
highest in general medicine wards.1 In the light of the 
human resource constraints in these countries,31 ne-
glect of occupational safety among HCWs, followed 
by their disinclination to continue general clinical 
work in the public sector, is a critical loss to the state 
of the health workforce.
Study characteristics
Semi-structured interviews allowed for an in-depth 
understanding of participants’ illness and return-to-
work experiences. The long follow-up period high-
lighted how TB among HCWs may facilitate attrition 
from the fi eld and deter a concerted effort to control 
the epidemic. Emergent themes may help enhance 
infection control education in medical curricula and 
practice, towards mitigating occupational risks. Larger 
studies are needed to quantify the psychosocial im-
pact of disease and HCW retention rates. 
CONCLUSION
Health care workers are not only at greater risk for 
acquiring TB, they also serve as potent vectors for 
TB transmission due to their greater contact with 
 immuno compromised patients. This issue is stronger 
yet in the cases of MDR-TB and extensively drug-
r esistant TB and in high HIV prevalence areas. The 
public sector is already battling against the better sal-
aries and work conditions offered to HCWs in better-
resourced countries and the private sector.31 There is 
a clinical and social imperative to prioritise infection 
control among HCWs, not only to reduce the risk of 
nosocomial transmission and prolonged morbidity, 
but also reduce the risk of the ‘brain drain’ in the 
health workforce.
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R É S U M É
C O N T E X T E  :   Le risque de tuberculose (TB), y compris 
celui de tuberculose à germes multirésistants (TB-MDR), 
est plus élevé chez les travailleurs des soins de santé (HCW) 
que dans la population générale. L’impact psychosocial 
de la TB nosocomiale sur les HCW n’a guère retenu 
l’attention dans la littérature.
M É T H O D E S  :   Une revue rétrospective des dossiers médi-
caux entre 1999 et 2003 a trouvé que 15 HCW avaient 
été traités pour une TB résistante aux médicaments 
dans un hôpital spécialisé d’Afrique du Sud. Cette série 
de cas comporte cinq médecins séronégatifs pour le virus 
de l’immunodéfi cience humaine n’ayant pas de facteurs 
prédisposant à la résistance aux médicaments. Nous 
présentons de manière collective leur histoire clinique en 
nous référant aux dossiers médicaux de 2000 à 2005 et 
nous explorons l’impact psychosocial à long terme de la 
TB à partir d’interviews menées en 2009.
O B S E RVAT I O N S  :   Chez quatre médecins, il s’agissait 
d’une TB-MDR primaire, tandis que chez un cette résis-
tance primaire concernait de multiples médicaments de 
première ligne. La période séparant le début des symp-
tômes et le début d’un traitement effi cace a été de 8 à 
39 semaines. La durée avant confi rmation bactériolo-
gique d’une TB résistante aux médicaments a varié de 6 
à 24 semaines. Tous ont été guéris dans les 3 ans après 
leur consultation initiale. L’analyse du contenu des inter-
views de suivi a révélé cinq thèmes : 1) prolongation de 
la morbidité, 2) impact psychosocial, 3) médiocre lutte 
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contre l’infection, 4) faiblesse des structures de soutien et 
5) perte pour le terrain.
C O N C L U S I O N  :   Les thèmes émergeant de cette série de 
cas plaident pour une priorité à donner à la lutte contre 
l’infection TB, à l’éducation et à la pratique pour mini-
miser la morbidité du personnel de santé et prévenir la 
perte de ce personnel dans des contextes à fardeau élevé 
et à ressources limitées. 
M A R C O  D E  R E F E R E N C I A :   Los profesionales de la salud 
(HCW) presentan mayor riesgo de contraer la tuberculo-
sis (TB) que la población general, incluida la tuberculosis 
multidrogorresistente (TB-MDR). En las publicaciones 
científi cas, se ha prestado poca atención a la repercusión 
psicosocial de la TB nosocomial de los HCW.
M É T O D O :   En un examen retrospectivo de los expedientes 
clínicos de 1999 al 2003 se encontraron 15 HCW tratados 
por TB farmacorresistente en un hospital de especialis-
tas en Sudáfrica. En esta serie de casos, hubo cinco médi-
cos con examen serológico negativo para el virus de la 
inmunodefi ciencia humana y sin factores predisponentes 
a la resistencia a los medicamentos. En el presente artí-
culo se presentan sus historias clínicas, a partir de los 
expedientes médicos del 2000 al 2005 y se analizan las 
repercusiones psicosociales de la TB a largo plazo, con 
base en entrevistas realizadas en el 2009.
R E S U LTA D O S :   Cuatro médicos presentaron TB-MDR 
primaria y uno presentó resistencia primaria a múltiples 
medicamentos antituberculosos de primera línea. El lapso 
entre la aparición de los síntomas y el comienzo del trata-
miento efi caz fl uctuó entre 8 y 39 semanas. El tiempo 
necesario para la confi rmación bacteriológica de la TB 
farmacorresistente osciló entre 6 y 24 semanas. Todos los 
casos alcanzaron la curación en los 3 años que siguieron 
a la presentación inicial. El análisis del contenido de las 
entrevistas de seguimiento puso en evidencia cinco as-
pectos principales: 1) la morbilidad prolongada; 2) la 
repercusión psicológica; 3) la insufi ciencia del control 
de las infecciones; 4) la defi ciencia de las estructuras de 
apoyo; y 5) el abandono del trabajo en el terreno.
C O N C L U S I Ó N :   Los temas que surgen a partir de esta se-
rie de casos inducen a dar prioridad a la educación y las 
prácticas dirigidas al control de la infección tuberculosa, 
a fi n de reducir al mínimo la morbilidad de los HCW y 
evitar la disminución del personal sanitario en los entor-
nos con alta carga de morbilidad y recursos limitados.
R E S U M E N
